Roflumilast Foam Effective for Scalp, Body Psoriasis in Phase 3 Trial

A phase 3 trial evaluating roflumilast foam in patients with scalp and body psoriasis met its coprimary and all secondary endpoints.

Related Keywords

,Drug Administration ,Scalp Investigator Global Assessment ,Body Investigator Global Assessment ,New Drug Application ,